XML 162 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Equity (USD $)
In Millions, except Share data
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Accumulated Translation Adjustment [Member]
Total
Balance at Jun. 30, 2010 $ 97.8 $ 1.4 $ (0.2) $ (25.3) $ 13.7 $ 87.4
Balance (in Shares) at Jun. 30, 2010 179,209,987   (479,779)      
Exchange differences on translation of foreign operations         18.8 18.8
Net loss       (25.4)   (25.4)
Total Comprehensive income           (6.6)
New shares issued on exercise of options 1.2 (1.2)        
New shares issued on exercise of options (in Shares) 1,394,548          
Shares issued to Welcome Trust 0.8         0.8
Shares issued to Welcome Trust (in Shares) 813,021          
Purchase of treasury shares     (0.8)     (0.8)
Purchase of treasury shares (in Shares)     (831,255)      
Share-based compensation   0.6       0.6
Balance at Jun. 30, 2011 99.8 0.8 (1.0) (50.7) 32.5 81.4
Balance (in Shares) at Jun. 30, 2011 181,417,556   (1,311,034)      
Exchange differences on translation of foreign operations         (3.0) (3.0)
Net loss       (19.2)   (19.2)
Total Comprehensive income           (22.2)
New shares issued on exercise of options 0.6 (0.6)        
New shares issued on exercise of options (in Shares) 932,760          
Purchase of treasury shares     (0.4)     (0.4)
Purchase of treasury shares (in Shares)     (505,144)      
Share-based compensation   0.5       0.5
Balance at Jun. 30, 2012 100.4 0.7 (1.4) (69.9) 29.5 59.3
Balance (in Shares) at Jun. 30, 2012 182,350,316   (1,816,178)     28,352,326
Exchange differences on translation of foreign operations         (4.2) (4.2)
Net loss       (8.7)   (8.7)
Total Comprehensive income           (12.9)
New shares issued on exercise of options 0.4 (0.4)        
New shares issued on exercise of options (in Shares) 413,335          
New shares issued on vesting of options on merger 1.1 (1.1)        
New shares issued on vesting of options on merger (in Shares) 4,639,104          
Acquisition of Nabi Biopharmaceuticals (98.5) 233.4 (115.7)     19.2
Acquisition of Nabi Biopharmaceuticals (in Shares) (153,398,048)   (4,051,183)      
Retirement of treasury shares (0.6) (116.5) 117.1      
Retirement of treasury shares (in Shares) (5,867,361)   5,867,361      
Restricted stock units, net (in Shares) 214,983          
Retirement of common stock (in Shares) (3)          
Share-based compensation   2.6       2.6
Balance at Jun. 30, 2013 $ 2.8 $ 118.7   $ (78.6) $ 25.3 $ 68.2
Balance (in Shares) at Jun. 30, 2013 28,352,326         28,352,326